Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study. Guo CG, Jiang F, Li Y, Chen Y, et al. J Antimicrob Chemother 2024;79:2263-2272.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo CG, Jiang F, Li Y, Chen Y, et al. Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study. J Antimicrob Chemother 2024;79:2263-2272.
PMID: 38973619